A Truncated Galectin-3 Isolated from Skin Mucus of Atlantic Salmon Salmo salar Binds to and Modulates the Proteome of the Gram-Negative Bacteria Moritella viscosa

• Published in: Marine Drugs
• Main Authors: Deepti Manjari Patel, Yoichiro Kitani, Kjetil Korsnes, Martin Haugmo Iversen, Monica Fengsrud Brinchmann
• Format: Article in Journal/Newspaper
• Language: English
• Published: MDPI AG 2020
• Subjects: galectin-3; bacteria; proteomics; gram-negative; lectin; innate immunology; mucosal immunology; agglutination; hemagglutination; multidrug transporter; Biology (General); QH301-705.5; Atlantic salmon; Salmo salar
• Online Access: https://doi.org/10.3390/md18020102; https://doaj.org/article/586ebd62bf1c4b70afb78a80c06f010d

The mucus of fish skin plays a vital role in innate immune defense. Some mucus proteins have the potential to incapacitate pathogens and/or inhibit their passage through the skin. In this study the aim was to isolate and characterize galectin(s), β-galactosides binding proteins, present in skin mucus. A novel short form of galectin-3 was isolated from Atlantic salmon skin mucus by α-lactose agarose based affinity chromatography followed by Sephadex G-15 gel filtration. Mass spectrometric analysis showed that the isolated protein was the C-terminal half of galectin-3 (galectin-3C). Galectin-3C showed calcium independent and lactose inhabitable hemagglutination, and agglutinated the Gram-negative pathogenic bacteria Moritella viscosa . Galectin-3 mRNA was highly expressed in skin and gill, followed by muscle, hindgut, spleen, stomach, foregut, head kidney, and liver. Moritella viscosa incubated with galectin-3C had a modified proteome. Proteins with changed abundance included multidrug transporter and three ribosomal proteins L7/12, S2, and S13. Overall, this study shows the isolation and characterization of a novel galectin-3 short form involved in pathogen recognition and modulation, and hence in immune defense of Atlantic salmon.